期刊档案 · Medicine-Medicine (miscellaneous)
Current Opinion in Biomedical Engineering
ISSN 2468-4511 · Elsevier
Current Opinion in Biomedical Engineering 中科院 医学 3区（2025 年升级版），影响因子 3.77，混合开放获取，APC 约 3,830 美元，出版商公布投稿到接收约 129 天，2025 年发文 70 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Current Opinion in Biomedical Engineering 由 Elsevier 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 3D Printing in Biomedical Research、Neuroscience and Neural Engineering、Electrospun Nanofibers in Biomedical Applications 等主题的论文，这 3 个主题约占 27.3%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Current Opinion in Biomedical Engineering provides systematic and focused reviews of the latest developments in different areas of the field of biomedical engineering. The Journal editors invite experts to evaluate the most innovative and interdisciplinary advances published in the previous 2 years. In addition to describing recent trends, authors will provide their subjective opinion on the topics discussed.Themed Sections: Each issue will review up to two of the major themes of biomedical engineering outlined below. In doing so, the Journal will serve as an invaluable resource to help bridge knowledge gaps amongst the researchers, academics, clinicians, professionals, and students with specializations in the various sub-disciplines of this field.BiomaterialsBiomechanics and mechanobiologyBiomedical imagingFuture of biomedical engineeringMolecular and cellular engineeringNeural engineeringNovel biomedical technologiesTissue engineering and regenerative medicineSelection of the topics to be reviewed: Section editors, who are major authorities in the field, are appointed by the Editor-in-Chief of the journal. They divide their section into a number of topics representing key subfields of the discipline, ensuring that the field is comprehensively covered and that all issues of current importance are emphasized. Section Editors, together with specialist Guest Editors, commission reviews from authorities on each topic that they have selected with the aim to stimulate exchange of ideas amongst experts. Editorial Board members are experts in the various subfields of the discipline, and support the Section Editors in the identification of important topical areas, Guest Editors, and prospective authors.Editorial Overview: Section Editors, together with the Guest Editors, will write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Medicine-Medicine (miscellaneous)
主编 George Truskey出版商官网
编委会国家分布：中国大陆 1 位（约 2%）；主要国家 美国 35、德国 6、澳大利亚 4、英国 2、荷兰 2（共 54 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- 3D Printing in Biomedical ResearchEngineering15.1%
- Neuroscience and Neural EngineeringNeuroscience6.4%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science5.9%
- Tissue Engineering and Regenerative MedicineMedicine5.9%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology5.7%
- Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology5.2%
- Bone Tissue Engineering MaterialsEngineering4.5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology4.4%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 工程：生物医学ENGINEERING, BIOMEDICAL | 4 区 |
Top 期刊：否综述期刊：是
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 工程：生物医学ENGINEERING, BIOMEDICAL | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）工程技术 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 工程技术 | 3 区 |
| 小类 | 工程：生物医学ENGINEERING, BIOMEDICAL | 4 区 |
Top 期刊：否综述期刊：是
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 3.77LetPub ·
- 影响因子（出版商公布）
- 3.8出版商官网 ·
- CiteScore 2026-06
- 8.9LetPub ·
- CiteScore（出版商公布）
- 8.9出版商官网 ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 61OpenAlex ·
- i10-index
- 335OpenAlex ·
- 两年平均被引
- 3.83OpenAlex ·
- 自引率
- 2.6%LetPub ·
- Gold OA 文章占比
- 29.11%LetPub ·
发文规模
- 年文章数
- 53LetPub ·
逐年发文量 OpenAlex 统计 · 累计 694 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 34 | 17 | 37 |
| 2025 | 70 | 35 | 317 |
| 2024 | 52 | 31 | 243 |
| 2023 | 75 | 40 | 947 |
| 2022 | 72 | 40 | 1,113 |
| 2021 | 102 | 52 | 2,152 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
出版商公布的审稿周期 期刊官网自述数据
129 天投稿到接收
出版商统计口径以官网为准；本刊近 24 个月的文章日期尚未获得，因此以官方数据为准。
各来源数据
- 投稿到首次决定
- 19 天出版商官网 ·
- 外审后首次决定
- 81 天出版商官网 ·
- 投稿到接收
- 129 天出版商官网 ·
- 接收到发表
- 6 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,830 / EUR 3,580 / GBP 3,070 / JPY 475,030 | — | — | |
| 出版商官网 | USD 4,040 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 1–7 个
- 正文篇幅
- ≤ 2,000 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- Highlights（研究亮点）
- 可选
接收的文章类型3 种，含篇幅限制
- invited review articlesInvited review articles: Authors write short review articles (2000 words or about 5-10 printed pages with figures) in which they present most recent development…未说明篇幅
- opinione into account when preparing a Current Opinion paper: 2000 word limit (excluding abstract, references and figure captions)正文 ≤ 2,000 词
- review articleing developments. Article types Invited review articles: Authors write short review articles (2000 words or about 5-10 printed pages with figures) in which they…正文 ≤ 2,000 词
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
团体作者署名必须在投稿时于标题页声明，通讯作者需协调相关沟通事宜。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响其工作的财务和个人关系，并完成声明工具。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项，建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
期刊引导作者查阅开放获取信息页面以了解开放获取选项。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
该期刊采用单盲同行评审，稿件通常由至少两名审稿人评审，编辑作出最终决定。 模型中文摘要
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按照Elsevier的文章共享政策分享预印本，分享预印本不计作先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- ISSN
- 2468-4511
- 官方链接
- 期刊主页 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Current Opinion in Biomedical Engineering 的常见问题
Current Opinion in Biomedical Engineering 是中科院几区期刊？
2025 年升级版分区表中，Current Opinion in Biomedical Engineering 为医学 3区，小类 工程：生物医学 4 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Current Opinion in Biomedical Engineering 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 3.77，CiteScore 为 8.9，h-index 为 61。
Current Opinion in Biomedical Engineering 的审稿周期多长？
出版商公布的投稿到接收时间约为 129 天。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Current Opinion in Biomedical Engineering 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：1–7 个；正文篇幅：≤ 2,000 词；参考文献格式：顺序编码制（按引用顺序编号）；Highlights：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Current Opinion in Biomedical Engineering 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 54 位编委中，中国大陆 1 位（约 2%）；人数最多的国家是 美国（35 位）、德国（6 位）、澳大利亚（4 位）。统计按编委会页面列出的机构国家计，仅供参考。
Current Opinion in Biomedical Engineering 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Current Opinion in Biomedical Engineering 被 SCIE、Scopus 收录。
Current Opinion in Biomedical Engineering 是开放获取期刊吗？版面费多少？
Current Opinion in Biomedical Engineering 为混合开放获取。选择开放获取发表时APC 约 3,830 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。